Search for: "Purdue Pharma Inc." Results 81 - 100 of 162
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
With AmerisourceBergen Drug Corporation, Purdue Pharma L.P., and Endo Pharmaceuticals Inc being sued previously. [read post]
12 Aug 2022, 6:48 pm by Lawrence B. Ebert
Amgen, 580 F.3d at 1365–67; Purdue Pharma L.P. v. [read post]
18 Sep 2016, 6:03 pm by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
6 Aug 2019, 3:50 am by Edith Roberts
” Briefly: At Dorf on Law, Michael Dorf explains why Arizona’s attempt “to sue members of the Sackler family and Purdue Pharma in the US Supreme Court … in the first instance is problematic. [read post]
30 Nov 2017, 8:59 pm by Brenda Fulmer
Counsel representing several Plaintiffs filed for consolidation of the actions of state, county, and municipal governments and other agencies against opiate manufacturers Purdue Pharma, Teva/Cephalon, Janssen, Endo, Actavis, and Mallinckrodt and distributors McKesson Corporation, AmerisourceBergen Corporation, and Cardinal Health, Inc. [read post]
4 May 2011, 7:52 am by Tron Emptage
Brand Name Opioid Products Generic Name Trade Name Applicant/Sponsors Fentanyl Duragesic Extended Release Transdermal System Ortho McNeil Janssen Hydromorphone *Palladone Extended Release Capsules Purdue Pharma   Methadone Dolophine Tablets Roxanne Morphine Avinza® Extended Release Capsules King Pharms   Morphine Kadian® Extended Release Capsules Actavis   Morphine MS Contin Extended Release Tablets … [read post]
12 Jul 2022, 9:38 am by Kelly Shivery
  We suspect the Purdue Pharma opioid settlement skewed the 2021 statistics. [read post]
8 Feb 2017, 3:09 am by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]